STAT+: Health AI investments are off to a roaring start in 2025
STAT
JANUARY 15, 2025
Qualified Health and Collate , two early stage generative AI startups, targeting hospitals and pharma respectively, each announced $30 million in funding.
ICEXPO announces Pharma Live Expo 2025 in Mumbai from April 17-19
Express Pharma
JANUARY 7, 2025
The 3rd edition of Pharma Live Expo & Summit will be held from April 17 to 19, 2025, at the Bombay Exhibition Centre, Mumbai. Pharma Live Expo & Summit 2025 provides a unique platform for stakeholders across the pharmaceutical value chain to come together, exchange knowledge, and drive impactful advancements.
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Pharma and healthcare deals in Q1 2025 remain stable amid shift to scalable global models
Express Pharma
APRIL 23, 2025
billion in Q1 2025, according to the Grant Thornton Bharat Pharma & Healthcare Dealtracker. When adjusted for that outlier, Q1 2025 shows a 15 per cent increase in deal value. M&A activity in Q1 2025 comprised 25 deals worth USD 1.5 Indias pharma and healthcare sector recorded 71 deals amounting to USD 2.6
Hospitals 
87
87 Hospitals 87
87 
Hospital supply chain pressures linger: 48 statistics
Beckers Hospital Review
JUNE 27, 2025
Hospital and health system leaders are continuing to navigate persistent upward pressure on supply and pharmaceutical expenses, with cost acceleration varying by region, according to Kaufman Hall’s “ National Hospital Flash Report ” based on data collected in April 2025 and released in early June.
Hospitals 59
59 Hospitals 59
59 
EM Match Advice 46 | Program Directors Share Match Season Insights
ALiEM - Pharm Pearls
JANUARY 29, 2025
Consider Location: Think beyond the hospital – where do you want to live for the next 3-4 years? Important Dates February 3, 2025: Rank list entry opens March 5, 2025: Rank list certification deadline March 21, 2025: Match Day Final Thoughts Remember that the Match algorithm favors applicant preferences.
Communication 161
161 
CPA recognised at the 2025 Nepal Pharmacists Association Conference
Commonwealth Pharmacists Association
JULY 2, 2025
Facilitating access to health resources Through national launch events, awareness campaigns, and targeted outreach, we are proud that the App is now being actively used in hospitals and universities across Nepal, including Dhulikhel Hospital , the teaching hospital of Kathmandu University.
Feds unveil largest healthcare fraud takedown: $14.6B in alleged schemes, 324 charged
Beckers Hospital Review
JUNE 30, 2025
The Justice Department, through its 2025 National Health Care Fraud Takedown investigation, has charged 324 defendants in schemes involving more than $14.6 The 2025 operation was the largest in the department’s history, more than double the previous record of $6 billion, according to a June 30 department news release.
Hospitals 117
117 Hospitals 117
117 
Patient Consent in RPM: A Non-Negotiable Compliance Step for US Healthcare in 2025
PharmD Live
JULY 1, 2025
But in 2025, RPM patient consent compliance is more than a billing formality; it is a legal, regulatory, and ethical imperative. To ethically deploy RPM in 2025: Providers must clearly explain how data flows across the care team Patients should know what third parties (e.g., April 15, 2025. Accessed June 26, 2025].
HIPAA 52
52 
Gerresheimer: FDA grants tentative approval of SQ innovation’s Lasix ONYU
Express Pharma
DECEMBER 16, 2024
Full approval is pending due to the FDA granting market exclusivity to a competing product until October 2025. The first market-ready products are expected by the end of 2025. Lasix ONYU supports home treatment for fluid overload in congestive heart failure, potentially reducing hospital stays and the overall cost of care.
Hospitals 105
105 Hospitals 105
105 
BD announces first pharma-sponsored clinical trial using BD Libertas wearable injector technology for biologic drugs
Express Pharma
JULY 23, 2025
iii) Pharma filled and assembled (iv) Mordor Intelligence (2025). Biologics Market Size – Industry Report on Share, Growth Trends & Forecasts Analysis (2025 – 2030). Clin Transl Sci. 2021 May;14(3):859-869. doi.org/10.1111/cts.12946.
Navigating 340B Program Changes in 2025
Proxsys Rx
APRIL 1, 2025
Maximizing pharmacys role in your hospitals revenue cycle The 340B landscape continues to evolve rapidly, with ongoing manufacturer restrictions, new compliance hurdles, and increasing financial pressures on covered entities. Recent estimates indicate that hospitals and clinics collectively lose around $3.2 Additionally, up to $8.4
9 drugs in shortage
Beckers Hospital Review
JULY 22, 2025
Supply is expected to last until September 2025. The post 9 drugs in shortage appeared first on Becker's Hospital Review | Healthcare News & Analysis. Ethionamide tablet : Pfizer has discontinued the manufacture of Trecator 250 milligram tablets, an anti-infective drug used in the treatment of tuberculosis.
Diabetes 59
59 
Programmatic Advertising Trends: Key Insights for Pharma Marketing Teams in 2025
Pharma Marketing Network
FEBRUARY 17, 2025
Introduction: In 2025, programmatic advertising will continue to redefine how pharmaceutical brands reach healthcare providers (HCPs) and patients. In this article, well explore key programmatic trends for 2025 and how they can help your campaigns become more targeted, efficient, and compliant.
Hospitals 52
52 Hospitals 52
52 
Avoiding Medicare Penalties: Navigating Challenges with PharmD Live Solutions
PharmD Live
JANUARY 8, 2025
Medicares increasing focus on quality metrics in 2025 presents critical challenges for healthcare providers. Critical Timelines: Performance Year 2024: Providers must track and manage quality metrics from January 1 to December 31, 2024, focusing on key areas such as medication adherence and hospital readmission rates.
Hospitals 52
52 
Biologic could reduce treatment burden for children with haemophilia A
European Pharmaceutical Review
FEBRUARY 7, 2025
The interim data from FRONTIER3 were presented at the 2025 Congress of the European Association for Haemophilia and Allied Disorders (EAHAD). Regulatory submission for Mim8 is anticipated in 2025. Data from the ongoing Phase III FRONTIER programme will be announced in 2025 and 2026, shared Novo Nordisk.
Hospitals 52
52 Hospitals 52
52 
Flu Vaccines Are a Go
Pharmacy Times
JULY 16, 2025
That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025. Editor's Footnote In May 2025, Secretary Robert F. Updated June 27, 2025.
Vaccines 40
40 
KFSHRC and Germfree to launch first modular ATMP manufacturing campus in Saudi Arabia
Pharmafile
JUNE 19, 2025
King Faisal Specialist Hospital & Research Centre (KFSHRC) has announced a landmark partnership with Germfree Laboratories to develop Saudi Arabia’s first fully integrated modular advanced therapy medicinal product (ATMP) manufacturing campus.
Hospitals 59
59 Hospitals 59
59 
Osivax reaches key milestone in phase 2a trial for broad-spectrum flu vaccine
Pharmafile
JUNE 6, 2025
The final results from the trial are expected in the second half of 2025. Conducted at the centre for vaccinology (CEVAC), Ghent University Hospital, Belgium, the trial investigated the safety […] The post Osivax reaches key milestone in phase 2a trial for broad-spectrum flu vaccine appeared first on Pharmafile.
Vaccines 64
64 
India’s life sciences sector poised for transformational growth: Vishal Goel
Express Pharma
DECEMBER 20, 2024
million hospital beds to meet global standards. Looking to 2025, Indias life sciences market is set for multi-fold growth, supported by policy interventions such as the PLI scheme, over $1.3 This year alone, we witnessed the demand for healthcare infrastructure skyrocket, with estimates indicating a need for an additional 1.3
Hospitals 52
52 Hospitals 52
52 
How to Be Successful on Your APPE Rotations?
UWorld | RxPrep
JULY 1, 2025
Share this blog July 1, 2025 Pharmacy School Quick Links Completing Advanced Pharmacy Practice Experiences (APPEs) is a pivotal step in your journey from pharmacy student to practicing professional. Flexibility and quick adaptation are key to thriving in diverse environments, from hospitals to ambulatory care. Try These Study Hacks!
UK enacts law to decentralise manufacture of personalised treatments
Pharmaceutical Technology
JULY 23, 2025
Abigail Beaney July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The new legislation will reduce the time it takes for patients to receive these therapies from months to days. Go deeper with GlobalData Reports China Contract Manufacturing Market Outlook - Trends, Ambitions, Ke.
Belgian Economic Mission to India highlights collaborations in lifesciences sector
Express Pharma
MARCH 5, 2025
As part of the ongoing Belgian economic mission to India, a titled Innovation for a Healthier World: Uniting Strengths from India and Belgium was held on March 5, 2025, at the Veermata Jijabai Botanical Udyan and Zoo in Mumbai.
Vaccines 80
80 
Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits
Pharmacy Times
JUNE 20, 2025
Furthermore, an investigation conducted by Norwalk et al found significant differences between Black and non-Black populations in pneumococcal mortality and length of hospital stay. Racial disparities in adult pneumococcal vaccination indications and pneumococcal hospitalizations in the US. J Natl Med Assoc. 2019;111(5):540-545.
Vaccines 29
29 
A closer look at how health care consolidation drives up patient costs, creates barriers to care
PhRMA
MARCH 17, 2025
Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program.
Hospitals 105
105 Hospitals 105
105 
AI That Pays Off: How Health Systems Are Reducing Avoidable Denials with Mid-Revenue Cycle Tech
Beckers Hospital Review
JULY 18, 2025
A new 2025 KLAS Second Look Report suggests that Xsolis’ Dragonfly, the next generation of the company’s AI-driven platform that improves medical necessity decision-making, is hitting the mark, delivering measurable outcomes to hospitals and health systems. The Bottom Line Hospitals can’t afford long implementations or soft ROI.
Hospitals 64
64 
Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?
Pharmacy Times
JUNE 24, 2025
Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting.
Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers
Pharmacy Times
JULY 16, 2025
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, showcased significant advances across a range of malignancies, with novel agents, biomarker-driven strategies, and long-term outcomes data offering new insights into cancer treatment with implications for pharmacy practice. June 5, 2025.
Novo Nordisk reports SOUL trial results showing reduced cardiovascular risk with oral semaglutide in type 2 diabetes
Express Pharma
APRIL 8, 2025
Hospital & Diabetes Institute, Kolkata, and adjunct Professor at Institute of Medical Science & SUM Hospital, Bhubaneswar, stated, The SOUL trial confirms that oral semaglutide significantly reduces cardiovascular risk in type 2 diabetes (T2D). .” Singh, Senior Consultant Endocrinologist at G.D.
Diabetes 89
89 
Jazz Pharma to pay $145 million to settle narcolepsy drug antitrust case
Express Pharma
APRIL 9, 2025
The plaintiffs, which include the city of Providence, Rhode Island, and the New York State Teamsters Council Health and Hospital Fund, lodged cases accusing Jazz of violating U.S. antitrust laws. The company reported sales of $233.8 million from Xyrem in the year 2024.
5 Things To Know About Interpreting MRSA Nares Swab Results
ID Stewardship
APRIL 16, 2025
BCPS, BCIDP Article Posted 16 April 2025 The methicillin-resistant Staphylococcus aureus (MRSA) naresswab (also referred to as a MRSA nasal swab) is a valuable tool for infection control programs, helping to identify which patients are colonized with MRSA and in turn may be at risk for MRSA infection. BCIDP & Timothy P. Gauthier, Pharm.D.,
Hospitals 52
52 Hospitals 52
52 
NHC Submits Comments on CMS Draft Guidance for IPAY 2028
Putting Patients First Blog
JUNE 26, 2025
While large hospitals may have dedicated reimbursement departments and billing vendors with direct access to CMS updates, smaller or rural practices often depend on Medicare Administrative Contractors (MACs) and third-party systems for claims processing guidance. 95 (May 15, 2025): 20674, https ://www.federalregister.gov/d/2025-08607.
Drug Pricing 52
52 
COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake
Pharmacy Times
JULY 25, 2025
Accessed July 23, 2025. Accessed July 23, 2025. Pneumococcal disease—pneumococcal vaccine recommendations. Last Updated October 26, 2024. CDC—AdultVaxView. Vaccination coverage among adults in the United States, National Health Interview Survey, 2022. Last Updated October 4, 2024. Hong K, Zhou F, Tsai Y, et al.
Vaccines 26
26 
Infusion Centers at a Crossroads: Why Operations-Informed AI is Key to Resilience in Cancer Care
Beckers Hospital Review
JULY 21, 2025
To better understand these challenges and how cancer centers are responding, LeanTaaS conducted a national survey of nearly 200 respondents from community hospitals, academic medical centers, and private oncology practices — including nursing directors, operational leaders, and administrators.
Hospitals 52
52 Hospitals 52
52 
Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact
Pharmacy Times
JUNE 20, 2025
Pharmacy Times : Can you share your experience at OPC 2025 and the significance of these meetings for pharmacists? Related Videos Related Content Advertisement June 20th 2025 Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy Kelley D. Sessions : Oncology Pharmacists Connect—this is the third year, right?
FDA Moving to Nonanimal Testing Methodologies in Preclinical Research
Pharmacy Times
JULY 22, 2025
2 In April 2025, the FDA announced its plan to phase out the animal testing requirements and require new approach methodologies (NAMs) in early research to streamline which treatments will be safe and effective in humans, reduce drug development costs and timelines, and reduce testing in animals. Accessed June 19, 2025. April 10, 2025.
The Changing Landscape of Pharmacy Accessibility
Pharmacy Times
JULY 22, 2025
Furthermore, delays in medication access can exacerbate chronic conditions, such as diabetes, hypertension, and asthma, leading to increased hospitalization rates. March 17, 2025. Accessed June 4, 2025. Patients may be unable to obtain critical medications, resulting in poor adherence and negative outcomes. 2022;62(6):1816-1822.
New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma
Pharmacy Times
JUNE 27, 2025
On January 16, 2025, the FDA approved acalabrutinib (Calquence; AstraZeneca) in combination with bendamustine and rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation (HSCT). January 16, 2025. Accessed May 14, 2025.
Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season
Pharmacy Times
JULY 21, 2025
Fournier, BSc Key Takeaways The 2024-2025 influenza season saw unprecedented severity, with high hospitalization and outpatient visit rates due to a vaccine mismatch and dominant H1N1 and H3N2 strains. 1 The US also reported the highest rates of hospitalizations and outpatient visits for flulike illnesses in 15 years.
Vutrisiran marks first silencer approved for ATTR-CM
Pharmaceutical Technology
JUNE 12, 2025
GlobalData Healthcare June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook European KOLs with cardiomyopathy patients told GlobalData that they are waiting for vutrisiran’s launch for ATTR-wt. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025
Pharmacy Times
JULY 12, 2025
1 Howard’s team built their telehealth service in collaboration with hospitals and health systems, especially to tackle the issue of hospital readmissions for Medicare and Medicaid patients—each of which can cost hospitals thousands of dollars.
Four Revelations from Minnesota’s First 340B Transparency Report
Drug Channels
DECEMBER 3, 2024
During next week’s Drug Channels Outlook 2025 live video webinar, he'll tell you what's ahead for the program that continues to defy gravity. I suspect similar reports are gonna be popular. And don't forget to put on your ruby slippers and hear from Doctor of Thinkology Adam J.
Drug Pricing 52
52 
Pharmacists Reimagine Myeloma Care With Insights from ASCO
Pharmacy Times
JUNE 24, 2025
In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO). Accessed June 24, 2025.
The Lifesaving Role of Continuous Glucose Monitors and Wearable Devices
Pharmacy Times
JULY 21, 2025
Accessed June 17, 2025. Updated February 2025. Accessed June 17, 2025. Related Videos Related Content Advertisement July 21st 2025 Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season Tori L. Health Sci Rep. 2025;8(4):e70747. doi:10.1002/hsr2.70747 Continuous glucose monitors. link] Miller EM.
Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment
Pharmacy Times
JUNE 9, 2025
A retrospective study presented at the American Society of Health-System Pharmacists 2025 Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations. Accessed June 9, 2025.
Let's personalize your content